(Stroke. 1995;26:1438-1443.)
© 1995 American Heart Association, Inc.
Articles |
Anti–Intercellular Adhesion Molecule–1 Antibody Reduces Ischemic Cell Damage After Transient But Not Permanent Middle Cerebral Artery Occlusion in the Wistar Rat
From the Henry Ford Health Sciences Center, Department of Neurology, Detroit, Mich (R.L.Z., M.C., N.J., J.P.); Oakland University, Rochester, Minn (M.C., W.X.T.); and the Upjohn Company, Department of Adhesion Biology, Kalamazoo, Mich (A.M.M., D.C.A.).
Correspondence to Michael Chopp, PhD, Neurology Department, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202.
Background and Purpose Postischemic cerebral inflammation may contribute to ischemic cell damage. Intercellular adhesion molecule–1 (ICAM-1) is a glycoprotein expressed on endothelial cells that facilitates leukocyte adhesion. We investigated the effect of administration of an anti–ICAM-1 antibody (1A29) on ischemic cell damage after transient (2-hour) or permanent middle cerebral artery (MCA) occlusion in the Wistar rat.
Methods Groups studied were as follows: (1) transient MCA occlusion: rats were subjected to 2 hours of MCA occlusion, and after 1 hour of reperfusion they were treated with 1A29 (n=11) or an isotype control antibody (n=9); and (2) permanent MCA occlusion: rats were treated with 1A29 (n=9) or an isotype control antibody (n=7) 2 hours after onset of MCA occlusion. All animals were killed 1 week after onset of ischemia. Brain sections were stained with hematoxylin and eosin for histological evaluation.
Results Significant reductions (P<.05) in both volume (44%) of the ischemic lesion and weight loss were found in animals subjected to transient MCA occlusion and treated with 1A29 compared with vehicle-treated animals. In contrast, in animals subjected to permanent MCA occlusion the lesion and the temporal profile of body weight were not altered by 1A29 administration.
Conclusions Ischemic cell damage is promoted by postischemic inflammatory response after 2 hours of transient MCA occlusion, and ischemic cell damage is reduced by administration of an anti–ICAM-1 antibody during reperfusion.
Key Words: cerebral ischemia, focal • leukocytes • middle cerebral artery • rats
This article has been cited by other articles:
 |
|
 |
|
  S. Jander, M. Schroeter, and A. Saleh Imaging Inflammation in Acute Brain Ischemia Stroke, February 1, 2007; 38(2): 642 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Danton and W. D. Dietrich The Search for Neuroprotective Strategies in Stroke AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 181 - 194. [Full Text] [PDF]
|
|
|
|
|
|
R. Vemuganti, R. J. Dempsey, and K. K. Bowen Inhibition of Intercellular Adhesion Molecule-1 Protein Expression by Antisense Oligonucleotides Is Neuroprotective After Transient Middle Cerebral Artery Occlusion in Rat Stroke, January 1, 2004; 35(1): 179 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Naidu, E. S. Fu, E. T. Sutton, L. D. Prockop, and A. Cantor The Therapeutic Effects of Epidural Intercellular Adhesion Molecule-1 Monoclonal Antibody in a Rabbit Model: Involvement of the Intercellular Adhesion Molecule-1 Pathway in Spinal Cord Ischemia Anesth. Analg., September 1, 2003; 97(3): 857 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Blann, P. M. Ridker, and G. Y.H. Lip Inflammation, Cell Adhesion Molecules, and Stroke: Tools in Pathophysiology and Epidemiology? Stroke, September 1, 2002; 33(9): 2141 - 2143. [Full Text] [PDF]
|
|
|
|
|
|
C.J.M. Frijns and L.J. Kappelle Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease Stroke, August 1, 2002; 33(8): 2115 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Furuya, H. Takeda, S. Azhar, R. M. McCarron, Y. Chen, C. A. Ruetzler, K. M. Wolcott, T. J. DeGraba, R. Rothlein, T. E. Hugli, et al. Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study Stroke, November 1, 2001; 32(11): 2665 - 2674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial Neurology, October 23, 2001; 57(8): 1428 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. del Zoppo, K. J. Becker, and J. M. Hallenbeck Inflammation After Stroke: Is It Harmful? Arch Neurol, April 1, 2001; 58(4): 669 - 672. [Full Text] [PDF]
|
|
|
|
|
|
W. M. Clark, L. G. Rinker, N. S. Lessov, S. L. Lowery, and M. J. Cipolla Efficacy of Antioxidant Therapies in Transient Focal Ischemia in Mice Stroke, April 1, 2001; 32(4): 1000 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fisher and W. Schaebitz An Overview of Acute Stroke Therapy: Past, Present, and Future Arch Intern Med, November 27, 2000; 160(21): 3196 - 3206. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kaplan, T. S. Park, E. R. Gonzales, J. M. Gidday, and J. A. Zivin Hydroxyethyl Starch Reduces Leukocyte Adherence and Vascular Injury in the Newborn Pig Cerebral Circulation After Asphyxia Editorial Comment Stroke, September 1, 2000; 31(9): 2218 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nonaka, J. Kiryu, A. Tsujikawa, K. Yamashiro, K. Miyamoto, H. Nishiwaki, M. Mandai, Y. Honda, and Y. Ogura Administration of 17{beta}-Estradiol Attenuates Retinal Ischemia-Reperfusion Injury in Rats Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2689 - 2696. [Abstract] [Full Text]
|
|
|
|
|
|
N. Kawai, M. Okauchi, K. Morisaki, S. Nagao, and W. D. Dietrich Effects of Delayed Intraischemic and Postischemic Hypothermia on a Focal Model of Transient Cerebral Ischemia in Rats Editorial Comment Stroke, August 1, 2000; 31(8): 1982 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Blann and G. Y. H. Lip Editorial: Cell Adhesion Molecules in Cardiovascular Disease and Its Risk Factors--What Can Soluble Levels Tell Us? J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1745 - 1747. [Full Text]
|
|
|
|
|
|
D. C. Hess, E. Howard, C. Cheng, J. Carroll, W. D. Hill, and C. Y. Hsu Hypertonic Mannitol Loading of NF-{kappa}B Transcription Factor Decoys in Human Brain Microvascular Endothelial Cells Blocks Upregulation of ICAM-1 Editorial Comment Stroke, May 1, 2000; 31(5): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa, E. Sekizuka, S. Sato, N. Yamaguchi, J. Inamasu, H. Bertalanffy, T. Kawase, and C. Iadecola Effects of Moderate Hypothermia on Leukocyte- Endothelium Interaction in the Rat Pial Microvasculature After Transient Middle Cerebral Artery Occlusion • Editorial Comment Stroke, August 1, 1999; 30(8): 1679 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vogel, C. Mobius, W. Kuschinsky, and W. I. Rosenblum Early Delineation of Ischemic Tissue in Rat Brain Cryosections by High-Contrast Staining • Editorial Comment Stroke, May 1, 1999; 30(5): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Zhang, Z. G. Zhang, M. Chopp, and J. A. Zivin Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain • Editorial Comment Stroke, March 1, 1999; 30(3): 624 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D BLANN and G. Y H LIP Cell adhesion molecules in cardiovascular disease: what can soluble levels tell us? Heart, January 1, 1999; 81(1): 101 - 102. [Full Text]
|
|
|
|
|
|
R. L. Zhang, Z. G. Zhang, and M. Chopp Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat Neurology, January 1, 1999; 52(2): 273 - 273. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bitsch, W. Klene, L. Murtada, H. Prange, and P. Rieckmann A Longitudinal Prospective Study of Soluble Adhesion Molecules in Acute Stroke Stroke, October 1, 1998; 29(10): 2129 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Bethea, M. Castro, R. W. Keane, T. T. Lee, W. D. Dietrich, and R. P. Yezierski Traumatic Spinal Cord Injury Induces Nuclear Factor-kappa B Activation J. Neurosci., May 1, 1998; 18(9): 3251 - 3260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pantoni, C. Sarti, and D. Inzitari Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 503 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martin-Ancel, A. Garcia-Alix, D. Pascual-Salcedo, F. Cabanas, M. Valcarce, and J. Quero Interleukin-6 in the Cerebrospinal Fluid After Perinatal Asphyxia Is Related to Early and Late Neurological Manifestations Pediatrics, November 1, 1997; 100(5): 789 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J.M. Frijns, L.J. Kappelle, J. v. Gijn, H.K. Nieuwenhuis, J.J. Sixma, and R. Fijnheer Soluble Adhesion Molecules Reflect Endothelial Cell Activation in Ischemic Stroke and in Carotid Atherosclerosis Stroke, November 1, 1997; 28(11): 2214 - 2218. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Oshiro, P. A. Hoffman, G. N. Dietsch, M. C. Watts, D. M. Pardoll, and R. J. Tamargo Inhibition of Experimental Vasospasm With Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody in Rats Stroke, October 1, 1997; 28(10): 2031 - 2038. [Abstract] [Full Text]
|
|